Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.61 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.60 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.60 |
| ▸ | AXL | P30530 | 1/20 | 0.60 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.55 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.55 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.53 |
| ▸ | KMO | O15229 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12373158 | 0.96 | NPY5R (0.58) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL21982139 | 0.96 | NPY5R (0.58) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL19009230 | 0.96 | NPY5R (0.58) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL19309598 | 0.94 | NPY5R (0.56) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL22693745 | 0.90 | CYP2A6 (0.60) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL18960598 | 0.89 | NPY5R (0.52) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL13624039 | 0.86 | CYP2A6 (0.56) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL18267891 | 0.86 | CYP19A1 (0.67) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL10262832 | 0.85 | CYP2A6 (0.65) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R | |
| SCHEMBL12070458 | 0.85 | CYP2A6 (0.65) | CYP2A6CYP3A4ALDH1A1CYP1A2NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663204-B1 | C-KIT MODULATORS AND METHODS OF USE | EXELIXIS INC (US) | 2014-05-07 | — | — | EP | claimed |
| US-20080096892-A1 | C-Kit Modulators And Methods Of Use | EXELIXIS, INC. (US) | 2008-04-24 | — | — | US | claimed |
| US-20240244946-A1 | ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS | LG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| WO-2024145931-A1 | SMALL MOLECULE INHIBITOR FOR β-CATENIN/BCL9 PROTEIN-PROTEIN INTERACTION AND USE THEREOF | 上海医药工业研究院有限公司 | 2024-07-11 | — | — | WO | disclosed |
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| EP-3935129-B1 | LIGANDS FOR NANO-SIZED MATERIALS | MERCK PATENT GMBH (DE) | 2023-11-29 | — | — | EP | disclosed |
| US-11832513-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11832513-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2023-11-28 | — | — | US | disclosed |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20050148623-A1 | Prevent reproduct of aids virus | ABBVIE INC. | 2005-07-07 | — | — | US | disclosed |
| WO-2004069158-A2 | SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK & CO., INC. (US) | 2004-08-19 | — | — | WO | disclosed |
| US-4937346-A | Phenyl-azacykloalkanes | Carlsson, Per Arvid Emil (SE) | 1990-06-26 | — | — | US | disclosed |
| US-4719219-A | Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders | Carlsson, Per A. E. (SE) | 1988-01-12 | — | — | US | disclosed |
| US-4426386-A | CNS DISORDERS | ASTRA LAKEMEDEL AKTIEBOLAG (SE) | 1984-01-17 | — | — | US | disclosed |
| EP-0084920-A2 | New compounds useful as intermediates or starting materials for preparation of therapeutically useful phenyl-azacycloalkanes | Carlsson, Per Arvid Emil (SE) | 1983-08-03 | — | — | EP | disclosed |
| EP-0030526-A1 | New phenyl-azacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds | Astra Läkemedel Aktiebolag (SE) | 1981-06-17 | — | — | EP | disclosed |
| WO-1981001552-A1 | NEW PHENYL-AZACYCLOALKANES | ASTRA LAEKEMEDEL AB (SE) | 1981-06-11 | — | — | WO | disclosed |
| US-4128651-A | Bis-quaternary pyridinium-2-aldoxime salts and a process for their preparation | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096892-A1 | C-Kit Modulators And Methods Of Use | KIT, PRKCH, PRKCB | CYP2A6 4760/4885CYP3A4 4747/4885ALDH1A1 2190/4885 |
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | CYP2A6 1085/4885CYP3A4 685/4885ALDH1A1 2814/4885 |
| US-11832513-B2 | Materials for electronic devices | PNMT, DDT, COMT | CYP2A6 120/4885CYP3A4 35/4885ALDH1A1 321/4885 |
| US-20050148623-A1 | Prevent reproduct of aids virus | SERPINB1, PRSS1, SERPINA3 | CYP2A6 580/4885CYP3A4 481/4885ALDH1A1 1209/4885 |
| US-20240244946-A1 | ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS | GPX1, PER2, SOD1 | CYP2A6 2160/4885CYP3A4 1109/4885ALDH1A1 10/4885 |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP2E1, GPX1, ERCC1 | CYP2A6 188/4885CYP3A4 114/4885ALDH1A1 115/4885 |
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, SOD1, ROS1 | CYP2A6 4425/4885CYP3A4 2401/4885ALDH1A1 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.